4-1BB costimulator/anti-TAA-3 conditional T-cell engager (Crescendo Biologics)

N/A

Report date: 2025/01/26 18:44:04

Base Information

Drug Name4-1BB costimulator/anti-TAA-3 conditional T-cell engager (Crescendo Biologics)
Drug Alias NameCD137/TAA-3 modulator (Crescendo)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulants
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCrescendo Biologics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A